International Stem Cell

(OTC) ISCO

Current Price$0.20

Market Cap$1.60M

Since IPO (2007)-100%

5 Year-73%

1 Year+57%

1 Month+18%

International Stem Cell Financials at a Glance

Market Cap

$1.60M

Revenue (TTM)

$9.29M

Net Income (TTM)

-$382.00K

EPS (TTM)

-$0.06

P/E Ratio

-3.39

Dividend

$0.00

Beta (Volatility)

0.37 (Low)

Dividend

$0.00

Beta (Volatility)

0.37 (Low)

Price

$0.20

Volume

66,372

Open

$0.16

Price

$0.20

Volume

66,372

Open

$0.16

Previous Close

$0.20

Daily Range

$0.16 - $0.20

52-Week Range

$0.12 - $0.27

Estimated Earnings Date

Aug 15, 2025

Dividend

$0.00

Beta (Volatility)

0.37 (Low)

Price

$0.20

Volume

66,372

Open

$0.16

Previous Close

$0.20

Daily Range

$0.16 - $0.20

52-Week Range

$0.12 - $0.27

Estimated Earnings Date

Aug 15, 2025

ISCO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About International Stem Cell

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Andrey Semechkin, PhD

Website

www.internationalstemcell.com

Headquarters

San Diego, CA 92131, US

ISCO Financials

Key Financial Metrics (TTM)

Gross Margin

56.98%

Operating Margin

-2.61%

Net Income Margin

-4.11%

Return on Equity

9.58%

Return on Capital

N/A

Return on Assets

-7.44%

Earnings Yield

-29.50%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.60M

Shares Outstanding

8.00M

Volume

66.37K

Avg. Volume

2.51K

Financials (TTM)

Gross Profit

$5.29M

Operating Income

-$242.00K

EBITDA

-$44.00K

Operating Cash Flow

-$98.00K

Capital Expenditure

-$61.00K

Free Cash Flow

-$159.00K

Cash & ST Invst.

$933.00K

Total Debt

$3.52M

International Stem Cell Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$2.32M

+8.7%

Gross Profit

$1.36M

+19.7%

Gross Margin

58.79%

N/A

Market Cap

$1.60M

N/A

Market Cap/Employee

$50.03K

N/A

Employees

N/A

Net Income

-$220.00K

+14.1%

EBITDA

-$156.00K

+2.5%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$933.00K

-35.7%

Total Debt

$3.52M

-14.0%

Accounts Receivable

$843.00K

-0.9%

Inventory

$1.77M

+40.9%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$3.52M

-7.2%

Return on Assets

-7.44%

N/A

Return on Invested Capital

-2.88%

N/A

Free Cash Flow

$98.00K

-55.9%

Operating Cash Flow

$121.00K

-46.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

EVFMEvofem Biosciences, Inc.

EVFMEvofem Biosciences, Inc.$0.01-9.09%

BMNDFBiomind Labs Inc.

BMNDFBiomind Labs Inc.$0.01+0.00%

NSTMNovelStem International Corp.

NSTMNovelStem International Corp.$0.01+0.00%

VCNXVaccinex, Inc.

VCNXVaccinex, Inc.$1.02+0.00%

DTRKDATATRAK International, Inc.

DTRKDATATRAK International, Inc.$0.18+0.00%

MRZMMarizyme, Inc.

MRZMMarizyme, Inc.$0.00+0.00%

CAIHFChia Tai Enterprises International Limited

CAIHFChia Tai Enterprises International Limited$0.28+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TAT&T

TAT&T$20.58+0.00%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.30-0.15%

CLROClearOne

CLROClearOne$6.48+1.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.35-0.05%

RIVNRivian Automotive

RIVNRivian Automotive$18.63+0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$39.95+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.50+0.03%

Questions About ISCO

What is the current price of International Stem Cell?

International Stem Cell is trading at $0.20 per share.

What is the 52-week range for International Stem Cell?

Over the past 52 weeks, International Stem Cell has traded between $0.12 and $0.27.

How much debt does International Stem Cell have?

As of the most recent reporting period, International Stem Cell reported total debt of $3.52M.

How much cash does International Stem Cell have on hand?

International Stem Cell reported $933.00K in cash and cash equivalents in its most recent financial results.

What is International Stem Cell’s dividend yield?

International Stem Cell does not currently have a dividend yield.

International Stem Cell

International Stem Cell Financials at a Glance

ISCO News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About International Stem Cell

ISCO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

International Stem Cell Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ISCO

What is the current price of International Stem Cell?

What is the 52-week range for International Stem Cell?

How much debt does International Stem Cell have?

How much cash does International Stem Cell have on hand?

What is International Stem Cell’s dividend yield?

Premium Investing Services